BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that Nancy A. Simonian, M.D. has been appointed to the company’s Board of Directors. Dr. Simonian is a biotechnology veteran with more than 16 years of global drug development experience, most recently as Chief Medical Officer at Millennium: The Takeda Oncology Company.
